Company Filing History:
1 out of 35 
1 out of 11 
1 out of 26 Years Active: 2018
Title: Innovations by Kazuko Kaneda: A Pioneering Mind in Antibody Research
Introduction
Kazuko Kaneda is a prominent inventor based in Miyazaki-shi, Japan, recognized for her significant contributions to the field of biotechnology. With a focus on developing antibodies that target specific cellular complexes, her work offers promising advancements in cancer treatment.
Latest Patents
Kazuko Kaneda holds a notable patent for an antibody that specifically reacts with human integrin A6B4. This invention aims to provide an anti-ITGA6/B4 human antibody, which precisely recognizes the ITGA6B4 complex expressed on cell membranes. The antibody inhibits adhesion to laminin, which is crucial in preventing cancer cells from adhering to the bone marrow niche. Additionally, it enhances the effectiveness of anticancer agents against resistant strains, marking a significant step forward in targeted cancer therapy.
Career Highlights
Throughout her career, Kazuko has made impactful strides in research and development, primarily associated with the University of Miyazaki and Fujita Health University. Her innovative approaches in immunology have positioned her as a key figure in scientific communities focused on cancer research.
Collaborations
In her journey, Kazuko has collaborated with talented professionals including Kazuhiro Morishita and Yoshikazu Kurosawa. These collaborations have fostered an environment of shared knowledge and expertise, enriching the research projects aimed at fighting cancer.
Conclusion
Kazuko Kaneda's contributions to the field of antibody research exemplify her dedication to innovation and tackling complex health challenges such as cancer. Her patent and collaborative efforts reflect the important role of inventors in advancing medical science and improving patient outcomes.